Volume quantification of intracardiac mass lesions by transesophageal three-dimensional echocardiography

Ahmed, Sujood; Nanda, Navin C.; Miller, Andrew P.; Nekkanti, Rajasekhar; Yousif, Abdalla; Pacifico, Albert D.; Kirklin, James K.; McGiffin, David C.

doi:10.1016/s0301-5629(02)00647-6

Cited by 26 publications

(29 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previous validation studies for left ventricular volume measurements were published with small inter‐ and intraobserver variability 10–12 . Intracardiac mass volume measurements by 3DE were validated on transesophageal 3D echocardiography 9 . The system used for this study permits the acquisition of the entire volume of the mass from a transthoracic approach, which makes it less invasive, fast, and easy to perform.…”

Section: Discussionmentioning

confidence: 99%

Real‐Time 3‐Dimensional Echocardiography Evaluation of Intracardiac Masses

et al. 2006

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Real‐Time 3‐Dimensional Echocardiography Evaluation of Intracardiac Masses

et al. 2006

View full text Add to dashboard Cite

show abstract

“…24,25 In Cases no. 1 and 2 tumor volume measured by live 3D TTE also correlated well with in vitro volume measured by immersing the resected myxoma in a water bath.…”

Section: This Preliminary Study Demonstrates the Superiority Of Live mentioning

confidence: 96%

Live Three‐Dimensional Transthoracic Echocardiographic Assessment of Left Atrial Tumors

Mehmood¹,

Nanda²,

Vengala³

et al. 2005

Echocardiography

View full text Add to dashboard Cite

This preliminary study demonstrates the superiority of live three-dimensional transthoracic echocardiography (3D TTE) over two-dimensional (2D) TTE in the assessment of left atrial (LA) tumors in four patients studied by us (three myxomas, one hemangioma, all subsequently pathologically proven). Because of the unique ability of live 3D TTE to systematically section and view the contents of an intracardiac mass, LA myxomas in the three patients studied could be more confidently diagnosed by noting isolated echolucent areas consistent with hemorrhage/necrosis in the tumor mass. On the other hand, a definite echolucent area was found by 2D TTE in only two of the three patients with myxoma. In the fourth patient with a hemangioma, live 3D TTE showed much more extensive and closely packed echolucencies with little solid tissue as compared to a myxoma consistent with a highly vascularized tumor. In contrast, 2D TTE demonstrated only two isolated echolucencies in the tumor suggesting an erroneous diagnosis of myxoma.

show abstract

“…1 In another consecutive analysis of 41 patients with cardiac masses, the same method underestimated the volume of intracardiac masses by approximately 20-25% compared to 3DTEE. Although 3DE has been available on some level for over two decades, it has only been available in real time mode for transthoracic echocardiography since 2002 and 2007 for transesophageal echocardiography.…”

mentioning

confidence: 93%

Real Time Three‐Dimensional Echocardiography Evaluation of Intracardiac Masses

2012

View full text Add to dashboard Cite

The evaluation of cardiac masses is often a challenge for cardiac imaging techniques. The traditional standby has been two-dimensional echocardiography (2DE). Real time three-dimensional echocardiography (RT3DE) offers incremental value for the evaluation of intracardiac masses by providing more accurate assessment of the size and shape of the mass as well as in some cases, composition of the mass. RT3DE aids with the relationship between the mass and adjacent structures. Therefore, here we discuss the subject of RT3DE evaluation of cardiac masses is reviewed and discussed in detail.

show abstract

Volume quantification of intracardiac mass lesions by transesophageal three-dimensional echocardiography

Cited by 26 publications

References 20 publications

Real‐Time 3‐Dimensional Echocardiography Evaluation of Intracardiac Masses

Real‐Time 3‐Dimensional Echocardiography Evaluation of Intracardiac Masses

Live Three‐Dimensional Transthoracic Echocardiographic Assessment of Left Atrial Tumors

Real Time Three‐Dimensional Echocardiography Evaluation of Intracardiac Masses

Contact Info

Product

Resources

About